Remdesivir - Covid-19

You are here : Home > Formulary Search > Remdesivir - Covid-19

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Intravenous infusion

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

Restrictions / Comments :

Documentation

Webpage

NICE TA971- Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 May24

Information

Covid Medicines Delivery Unit- update to NICE TA 878 -June 24.pdf

PAD Profile

ChemicalSubstance :

Remdesivir

Indication :

Covid-19

Group Name :

Keywords :

Covid 19, Coronavirus, antivirals

Brand Names Include :

Veklury

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Remdesivir is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Covid-19.

Committee Recommendations (1)

03 Jul 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System agreed a RED traffic light status for Remdesevir in line with NICE TA971